Gene Therapy for Sickle Cell Disease – Moving from the Bench to the Bedside

Advances in genomic sequencing, increased understanding of hemoglobin regulation and discoveries of molecular tools for genome modification of hematopoietic stem cells have made gene therapy for sickle cell disease possible. These therapies need to be portable, safe and efficient to make an in vivo based approach attractive.